Based in California, Reid supervises the execution of our international surveys, an expertise he’s developed after 15 years of working with emerging biopharmaceutical companies. Reid Bengard MBA has run major qualitative and quantitative market research studies for biotechnology and pharmaceutical companies since 1997. His research experience spans dozens of therapeutic categories across established and emerging markets and includes every major stakeholder group from physicians, nurses, pharmacists and patients to payers and thought leaders.

Prior to working with groupH, he held senior positions at ZS Associates and Ziment (now Kantar Health). He holds a BSc from the University of California at Davis and an MBA from the Wharton School of the University of Pennsylvania.